Skip to main content
. 2017 Aug 18;7:8725. doi: 10.1038/s41598-017-08975-y

Figure 5.

Figure 5

Epac1−/− mice exhibit a delayed rate of clot formation and fragile clot stability ex vivo. ROTEM characterization of the coagulation process in citrated whole blood from WT and Epac1−/− mice. Activated CT: clotting time i.e., the latency until the clot reaches a firmness of 2 mm, CFT: clot formation time and MCF: maximum clot firmness in mm was assessed by ROTEM assays (A) INTEM, (B) EXTEM and (C) FIBTEM. In FIBTEM assays the actin polymerization and platelet activation blocker cytochalasin D is present. Each point represents the measurements of one mouse. The horizontal dotted lines represent the median, n = 5–11 mice per group. *P < 0.05, **P < 0.01, Student’s t-test.